A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

Life expectancy for men lags five years behind life expectancy for women in the U.S. Some researchers and doctors say greater attention to men's health could bridge the gap.

A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...

The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.

Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients ...

Nearly one in eight men will be diagnosed with prostate cancer and, as a new UCSF study finds, significantly more of these ...

Real-world data support trial data on the use of lutetium-177 PSMA-617 in patients with PSMA-positive, metastatic castration-resistant prostate cancer.

Radium-223 is an alpha-emitting radiopharmaceutical that accumulates in areas of high bone turnover and has demonstrated a survival benefit in metastatic prostate cancer, 1 but its benefits as a ...

(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Ivan de Kouchkovsky discussing the impact of baseline PSMA PET in patients with metastatic ...

Providence Alaska Medical Center will be the first in the state to offer Pluvicto, an innovative therapy for metastatic ...